Dose Insider / Glossary / Contrave

ContraveWhat it is, how it is taken and how it compares

Updated November 20, 2026 路 3 min read 路 CONTRAVE prescribing information, DailyMed, November 2025

Contrave is a weight-management tablet that combines two older medicines: naltrexone, an opioid antagonist, and bupropion, an antidepressant. Used with a reduced-calorie diet and more physical activity, it is approved to lower body weight and keep it off in adults with obesity, or with overweight and at least one weight-related condition.

8.1%Intensive behavior program, Contrave, weight lost by week 56
Weight lost by week 56Contrave label trials, % of starting weightDIET ADVICEContrave5.4%Placebo1.3%INTENSIVE BEHAVIOR PROGRAMContrave8.1%Placebo4.9%Weight lost by week 56Contrave label trials, % of starting weightDIET ADVICEContrave5.4%Placebo1.3%INTENSIVE BEHAVIOR PROGRAMContrave8.1%Placebo4.9%

42% lost at least 5% of their weight on Contrave, against 17% on placebo.

On this page

It was first approved in the United States in 2014 and is not a GLP-1 medicine.1

What it is

Each extended-release tablet holds 8 mg of naltrexone hydrochloride and 90 mg of bupropion hydrochloride. On its own, bupropion is used to treat depression and to help people stop smoking, and naltrexone to help people who have stopped drinking or using opioids control cravings.2,3 Because Contrave contains bupropion, it carries the boxed warning that antidepressants share. It describes a higher risk of suicidal thoughts and behavior in children, teenagers and young adults taking antidepressants, and asks for monitoring for worsening mood or new suicidal thoughts.1

How the dose climbs

Contrave is taken by mouth, swallowed whole, and climbs over three weeks to two tablets twice a day.1

WeekMorningEvening
11 tabletNone
21 tablet1 tablet
32 tablets1 tablet
4 onward2 tablets2 tablets

CONTRAVE prescribing information, Table 1.1

From week 4 the daily total is 32 mg of naltrexone and 360 mg of bupropion. The label sets a check: after 12 weeks at that maintenance dose, an adult who has not lost at least 5% of starting weight should stop, because meaningful weight loss is then unlikely with more treatment.1 Counting the three weeks of the climb, that check falls at about week 16.

What it did in trials

Three 56-week trials support the approval.1

Those losses are smaller than in the trials of the weekly GLP-1 medicines, such as 14.9% on Wegovy over 68 weeks, though no trial put the two against each other.4 The difference in mechanism also matters. GLP-1 medicines act on gut hormone receptors; Contrave acts on the brain through an opioid blocker and an antidepressant, so it suits different people and raises different safety questions.

Side effects and who should not take it

In the label's trials, nausea was reported by 32.5% on Contrave against 6.7% on placebo, constipation by 19.2% against 7.2% and headache by 17.6% against 10.4%. Vomiting was reported by 10.7% against 2.9%, dizziness by 9.9% against 3.4% and insomnia by 9.2% against 5.9%.1

The label rules Contrave out for people with uncontrolled high blood pressure, a seizure disorder or past seizures, bulimia or anorexia nervosa, or long-term use of opioids such as methadone or buprenorphine. It also rules it out alongside other bupropion products and during an abrupt stop of alcohol or benzodiazepines.1 Because naltrexone blocks opioids, the label warns that opioid painkillers, cough remedies and antidiarrheals may not work fully, and that trying to overcome the block with large opioid doses can cause a fatal overdose.1

Contrave in eight lines

FactContrave
Active ingredientsNaltrexone and bupropion
First U.S. approval2014
FormExtended-release tablet
Full dose2 tablets twice a day, from week 4
Stop ruleUnder 5% lost after 12 weeks at full dose
Boxed warningSuicidal thoughts and behaviors
Is it a GLP-1No
Approved forWeight, in adults

CONTRAVE prescribing information, DailyMed version of November 17, 2025.1

Qsymia is the other combination tablet for weight, built from phentermine and topiramate. Our page on GLP-1 costs without insurance lists self-pay prices of the injections and tablets, and alcohol on a GLP-1 covers the research on GLP-1 medicines and drinking.

Sources

  1. CONTRAVE (naltrexone HCl and bupropion HCl) extended-release tablets prescribing information. DailyMed, U.S. National Library of Medicine, version published November 17, 2025; boxed warning and sections 1, 2, 4, 5, 6.1, 7.2 and 14. dailymed.nlm.nih.gov
  2. MedlinePlus. Naltrexone. U.S. National Library of Medicine; last revised September 15, 2026, read November 20, 2026. medlineplus.gov
  3. MedlinePlus. Bupropion. U.S. National Library of Medicine; last revised November 15, 2025, read November 20, 2026. medlineplus.gov
  4. WEGOVY (semaglutide) prescribing information, NDA 215256/S-025, revised June 2026. U.S. Food and Drug Administration; section 14. accessdata.fda.gov

Related analyses

Log each tablet and your weight, and see week 16 coming.

Open Dose Insider